Product Image

MK-7 90 mcg

4.8
★ ★ ★ ★ ★
(76 ratings)
Vitamin K 90 mcg
Product Image
Score83
A focused 90 mcg natural MK-7 softgel with a practical daily dose. Missing source and carrier details are the main limitations.
How scoring works
Softgel
Quantity:60 Softgel(s) • (60 servings)
Goals:
Heart Health
Bone Health
Cardiovascular Support

Score 83

A focused 90 mcg natural MK-7 softgel with a practical daily dose. Missing source and carrier details are the main limitations.
How scoring works
$16.99($0.28 per serving)
Pure Formulas
$ 16.99
Daily Vita
$ 17.99
Daily Vita
$ 17.99
Vitacost
$ 17.59
Vitacost
$ 20.75
Report prices

Analysis

One softgel supplies 90 mcg of natural menaquinone-7. The long-lasting K2 form is a practical choice for vitamin K-dependent bone and vascular proteins.

Softgel delivery can support a fat-soluble nutrient, although the carrier oil is not identified in the supplied record. No branded source or additional purity information is given.

The single-active design suits people who already manage vitamin D and minerals separately. It offers a useful K2 amount without unnecessary dose escalation.

Who is it for
  • Adults seeking standalone MK-7
  • People who prefer softgels
  • Users already covering vitamin D separately
Best for
  • Daily vitamin K2 supplementation
  • Bone calcium-management support
  • Simple softgel use

Pros

  • Uses natural MK-7
  • Provides a practical 90 mcg amount
  • Offers softgel delivery
  • Keeps the formula focused

Cons

  • Does not identify a branded MK-7 source
  • Does not name the carrier oil
  • Does not include vitamin D
  • Provides no added purity detail

Warnings

  • Vitamin K2 can oppose warfarin and related vitamin K antagonists, so intake should remain consistent with prescriber guidance.

Nutrient quality

93 Highest impact

Menaquinone-7 is a well-regarded, longer-acting vitamin K2 form. The vitamin K amount is meaningful for routine supplementation.

Ingredient transparency

82 Highest impact

Every active ingredient has a specific amount. Inactive ingredients are not supplied.

Customer satisfaction

64 Moderate impact

The supplied average indicates very strong aggregate satisfaction. No detailed experience reports are available to identify repeated complaints or confirm perceived benefits.

Value for money

88 Highest impact

The focused, well-formed ingredient provides reasonable value for the cost. Serving value appears moderate for a simple vitamin K supplement.

Report analysis

Goals

Heart Health
Impact
Highest effect
A- Goal FitA Strength of SupportC CoverageA+ Formula Quality
Vitamin K · 90 mcg

Natural MK-7 directly supports arterial calcium management at a well-aligned 90 mcg amount. The softgel format is suitable for a fat-soluble vitamin and the label is easy to evaluate.

The single-ingredient design gives strong depth to one pathway but does not address lipids, vascular tone, cardiac energy, or homocysteine. People using warfarin or another vitamin K antagonist should keep vitamin K intake consistent with their anticoagulation plan.

Study evidence
Vitamin K Mixed 62 studies
Bone Health
Impact
High effect
B+ Goal FitB+ Strength of SupportD+ CoverageA Formula Quality
Vitamin K · 90 mcg

Natural MK-7 directly supports the proteins that help guide calcium into bone tissue. As a single vitamin, it does not supply calcium, magnesium, vitamin D, or collagen support.

The amount reaches the lower end of a useful target and the softgel suits a fat-soluble vitamin. The streamlined formula has excellent depth and transparency for vitamin K but narrow pathway coverage.

Study evidence
Vitamin K Supportive 78 studies
Impact
High effect
B- Goal FitA Strength of SupportD CoverageA+ Formula Quality
Vitamin K · 90 mcg

Natural MK-7 vitamin K2 supports activation of proteins involved in directing calcium away from soft tissues. The disclosed amount reaches a practical targeted range and softgel delivery suits a fat-soluble vitamin.

The product covers one narrow calcium-management pathway and omits complementary vitamin D3. Vitamin K2 can counteract warfarin and related vitamin K antagonists, so users of those medicines need consistent intake and clinician guidance.

Study evidence
Vitamin K Supportive 40 studies

Ingredients

IngredientAmount per serving
Vitamin K2 (as natural MK-7)
90 mcg
Gluten Free Adults 18–50 Dairy Free
Report overview
B Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyA+ Value

Natural MK-7 reaches the lower boundary of the targeted clinical range at very low serving cost. The softgel likely supports fat-soluble delivery, although the supplied facts do not name its oil carrier or an all-trans guarantee. People using warfarin or another vitamin K antagonist should keep vitamin K intake consistent and follow their anticoagulation plan.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.
    Knapen MH; Drummen NE; Smit E; Vermeer C; Theuwissen E · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2014
    Randomized trial244 participantsBone Health forVitamin K
  2. Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials.
    Huang ZB; Wan SL; Lu YJ; Ning L; Liu C; Fan SW · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2015
    Meta-analysis6,759 participants19 studies pooledBone Health forVitamin K
  3. Investigating the interrelationship of vitamin K and vitamin D status on bone density: results from the VITamin D and OmegA-3 TriaL.
    Chou SH; Booth SL; Cook NR; Kim E; Kotler G; Fu X; Buring JE; Manson JE; LeBoff MS · JBMR plus · 2026
    Randomized trial771 participantsBone Health forVitamin K
  4. Comparison of concurrent treatment with vitamin K2 and risedronate compared with treatment with risedronate alone in patients with osteoporosis: Japanese Osteoporosis Intervention Trial-03.
    Tanaka S; Miyazaki T; Uemura Y; Miyakawa N; Gorai I; Nakamura T; Fukunaga M; Ohashi Y; Ohta H; Mori S; Hagino H; Hosoi T; Sugimoto T; Itoi E; Orimo H; Shiraki M · Journal of bone and mineral metabolism · 2018
    Randomized trial1,874 participantsBone Health forVitamin K
  5. Efficacy and safety of vitamin K2 for postmenopausal women with osteoporosis at a long-term follow-up: meta-analysis and systematic review.
    Zhou M; Han S; Zhang W; Wu D · Journal of bone and mineral metabolism · 2022
    Meta-analysis6,853 participants9 studies pooledBone Health forVitamin K
  6. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial.
    Knapen MH; Braam LA; Drummen NE; Bekers O; Hoeks AP; Vermeer C · Thrombosis and haemostasis · 2016
    Randomized trial244 participantsCardiovascular Support Heart Health forVitamin K
  7. Effects of One-Year Menaquinone-7 Supplementation on Vascular Stiffness and Blood Pressure in Post-Menopausal Women.
    de Vries F; Bittner R; Maresz K; Machuron F; Gåserød O; Jeanne JF; Schurgers LJ · Nutrients · 2025
    Randomized trial165 participantsCardiovascular Support forVitamin K
  8. Vitamin K Intake and Atherosclerotic Cardiovascular Disease in the Danish Diet Cancer and Health Study.
    Bellinge JW; Dalgaard F; Murray K; Connolly E; Blekkenhorst LC; Bondonno CP; Lewis JR; Sim M; Croft KD; Gislason G; Torp-Pedersen C; Tjønneland A; Overvad K; Hodgson JM; Schultz C; Bondonno NP · Journal of the American Heart Association · 2021
    Cohort study53,372 participantsCardiovascular Support Heart Health forVitamin K
  9. Interventions to Attenuate Cardiovascular Calcification Progression: A Systematic Review of Randomized Clinical Trials.
    Murali S; Smith ER; Tiong MK; Tan SJ; Toussaint ND · Journal of the American Heart Association · 2024
    Systematic review9,901 participants49 studies pooledCardiovascular Support forVitamin K
  10. Intake of dietary phylloquinone and menaquinones and risk of stroke.
    Vissers LE; Dalmeijer GW; Boer JM; Monique Verschuren WM; van der Schouw YT; Beulens JW · Journal of the American Heart Association · 2014
    Cohort study35,476 participantsCardiovascular Support forVitamin K
  11. Circulating uncarboxylated matrix Gla protein, a marker of vitamin K status, as a risk factor of cardiovascular disease.
    van den Heuvel EG; van Schoor NM; Lips P; Magdeleyns EJ; Deeg DJ; Vermeer C; den Heijer M · Maturitas · 2014
    Cohort study577 participantsCardiovascular Support forVitamin K
  12. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials.
    Cockayne S; Adamson J; Lanham-New S; Shearer MJ; Gilbody S; Torgerson DJ · Archives of internal medicine · 2006
    Meta-analysis13 studies pooledBone Health forVitamin K
  13. Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis.
    Iwamoto J; Takeda T; Ichimura S · Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association · 2001
    Randomized trial92 participantsBone Health forVitamin K
  14. Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women.
    Koitaya N; Sekiguchi M; Tousen Y; Nishide Y; Morita A; Yamauchi J; Gando Y; Miyachi M; Aoki M; Komatsu M; Watanabe F; Morishita K; Ishimi Y · Journal of bone and mineral metabolism · 2015
    Randomized trial48 participantsBone Health forVitamin K
  15. Dietary Vitamin K1 Intake and Incident Aortic Valve Stenosis.
    Schultz CJ; Dalgaard F; Bellinge JW; Murray K; Sim M; Connolly E; Blekkenhorst LC; Bondonno CP; Lewis JR; Gislason GH; Tjønneland A; Overvad K; Hodgson JM; Bondonno NP · Arteriosclerosis, thrombosis, and vascular biology · 2024
    Cohort study55,545 participantsCardiovascular Support Heart Health forVitamin K
  16. Association between vitamin K1 intake and mortality in the Danish Diet, Cancer, and Health cohort.
    Palmer CR; Bellinge JW; Dalgaard F; Sim M; Murray K; Connolly E; Blekkenhorst LC; Bondonno CP; Croft KD; Gislason G; Tjønneland A; Overvad K; Schultz C; Lewis JR; Hodgson JM; Bondonno NP · European journal of epidemiology · 2021
    Cohort study56,048 participantsCardiovascular Support Heart Health forVitamin K
  17. The effect of vitamin K1 on arterial calcification activity in subjects with diabetes mellitus: a post hoc analysis of a double-blind, randomized, placebo-controlled trial.
    Bellinge JW; Francis RJ; Lee SC; Bondonno NP; Sim M; Lewis JR; Watts GF; Schultz CJ · The American journal of clinical nutrition · 2022
    Randomized trial149 participantsHeart Health forVitamin K